LA JOLLA, Calif. — Singular Genomics Systems, Inc. (“Singular Genomics”), a company focused on delivering genomic technologies for the advancement of science and medicine, today announced the closing of its initial public offering of 11,730,000 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 1,530,000 additional shares of […]
Capital will enable continued advancement of GenapSys’ electronic-based, next-generation sequencing platform REDWOOD CITY, Calif. — GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced it has raised $70 million in a Series D equity financing. Investors in the round included Farallon Capital Management, L.L.C., Soleus Capital, an affiliate of PBM […]
Largest private financing round by an Asia-based life sciences tools company Important milestone in the development of Novo Holdings’ ambitions in Asia As a result of the financing, Amit Kakar, Senior Partner, Head of Novo Holdings Asia will join the company’s Board of Directors Singapore & Copenhagen, Denmark – Novo Holdings today announced that it […]
Largest private fundraising round by an Asia-based life sciences tools company SINGAPORE — Esco Lifesciences (“Esco”, the “Company”) announced today the close of an over-subscribed US$200 million Series A and Crossover round. The financing was led by Vivo Capital and Novo Holdings A/S, with participation from new investors including China Investment Corporation, Singapore-based global investor EDBI, […]
Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, today announced the successful completion of Series A4 financing. Sequoia Capital China led this round of investment, and was joined by Green Pine Capital Partners and Primavera Venture Partners. IDG Capital, the original founding investor for Analytical Biosciences, also participated in this financing round. Analytical […]
CAPZA, an independent management company and leading player in private investments in European SMEs – invests in Xenocs, a French deep tech company, through its new Growth Tech strategy. Founded in 2000, Xenocs is a spin-off from the Institut Laue-Langevin (ILL). The company operates on the nanoscale material characterization market through the development and production […]
Marlborough, MA: Scitara Corporation, a global provider of laboratory-specific, cloud-based software solutions for the biopharmaceutical and industrial markets, today announced the closing of $5 million in a Series A round. The investment was led by Northpond Ventures, with participation from existing investor Flybridge Capital. Scitara will use the investment to fully build out its Digital Lab Exchange™ (DLX) platform, partner […]
Industry Veteran Brian Dutko Named New CEO to Support a Transformational Growth Strategy, Including Pursuit of Strategic Acquisitions RYE, N.Y. and BILLERICA, Mass. — SFW Capital Partners, LP (“SFW”) today announced that it has completed a majority recapitalization of Pion Inc. (“Pion”), a leading provider of analytical instrumentation for formulation development and quality control in the life sciences industry. Mike and […]
Funding will be used to advance the development of AI-based cell analysis and sorting platforms in cell therapy and diagnostics Tokyo, Japan — ThinkCyte, Inc., a company focusing on the development of novel cell therapy, drug discovery and diagnostic platforms, announced today the completion of a $26 million (JPY 2.85 billion) Series B financing, led […]
M12 – Microsoft’s Venture Fund – leads Artificial’s Series A to accelerate product development, grow its world-class team, and establish life science partnerships to advance breakthroughs Palo Alto, Calif – Business Wire – Artificial, a software company providing a first-of-its-kind lab automation platform, announced today the close of their $21.5M Series A investment round. The […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
